Best in Biotech 19 Nov 2025 Eight CAR-T cell therapy companies you should know about Discover eight promising companies advancing their CAR-T cell therapy candidates in the clinic and have made the headlines in 2025. November 19, 2025 - 16 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Sponsored by Lonza 18 Nov 2025 On the fast track to the clinic: early decisions in drug development As biologics grow more complex, Lonza helps biotech firms accelerate from DNA to IND with tailored strategies that cut risk and speed development. November 18, 2025 - 7 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Sponsored by VALIDOGEN 4 Nov 2025 Rethinking protein production: Why Pichia pastoris is gaining ground in biotech Pichia pastoris is emerging as a versatile, efficient alternative for protein production, bridging microbial and mammalian expression systems. November 4, 2025 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 22 Oct 2025 PCSK9’s second act: From antibodies to gene editing With Eli Lilly’s recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents. October 22, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 1 Oct 2025 Asthma study suggests lung scarring may be reversible Find out about this new study that suggest that the lung scarring that severe asthma can cause could be reversible. October 1, 2025 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Sponsored by Lonza 9 Sep 2025 Advanced expression vector design to overcome challenges in developing multichain biotherapeutics Learn how multichain biotherapeutics like bispecific antibodies and Fc-fusion proteins overcome manufacturing challenges with advanced vectors and expression systems. September 9, 2025 - 8 minutesmins - By Jennifer Tsang Share WhatsApp Twitter Linkedin Email
In Depth 1 Sep 2025 Blood Cancer Awareness Month: What biotech holds in store As September marks the beginning of Blood Cancer Awareness Month, delve into what is being developed in the biotech pipelines. September 1, 2025 - 13 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 6 Aug 2025 Fusion proteins attract funds and biopharma partnerships Fusion proteins have drawn investors these past months attracting dollars from deep pockets in the pursuit of commercial success. August 6, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 2 Jul 2025 Top biotech deals in June 2025 Learn about June 2025’s top biotech deals, featuring major collaborations in small molecules, protein therapeutics, and immunotherapies. July 2, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 18 Jun 2025 From undruggable to oral therapy: The rise of STAT6 degraders Delve into the STAT6 degrader technology and what it could bring to inflammatory and allergic disease treatment. June 18, 2025 - 5 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 27 May 2025 Interleukin therapeutics: 9 companies to follow in 2025 Interleukins — a group of signaling proteins that help immune cells communicate — have long been recognized as powerful tools in modulating immune responses. Over the years, companies have explored interleukin as treatments for cancer, autoimmune conditions, and inflammatory diseases. But while some interleukin-based drugs have reached the market, many early attempts were held back […] May 27, 2025 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 23 May 2025How generative AI and ‘Photoshop for proteins’ are transforming biopharma R&D Generative artificial intelligence’s biggest impacts on biotech are still to come. Learn more in our talk with Cradle Therapeutics’s co-founder, Elise de Reus. May 23, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More